A project focused on cancer research at Fred Hutchinson Cancer Center.
Official title: ConProject-001
Funded at Fred Hutchinson Cancer Center · NIH-11299093 · Data updated 2026-11-12
This study is looking at new and exciting ways to treat and prevent cancer, and it’s for patients who want to be part of innovative therapies that could help improve cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | January 30, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $163,398 |
| NIH project number | 3U19AI174242-03S1 |
| Project ID | NIH-11299093 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would include individuals diagnosed with cancer or those at high risk for developing cancer.
✕Less likely to help
Patients with conditions unrelated to cancer may not receive any benefit from this research.
What this research studies
This research investigates innovative approaches to cancer treatment and prevention at the Fred Hutchinson Cancer Center. The project aims to explore various methodologies that could lead to improved patient outcomes. While specific details are not provided, the research is likely to involve collaboration among experts in oncology and may include clinical trials or observational studies. Patients may have the opportunity to participate in cutting-edge therapies or contribute to advancing cancer knowledge.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for cancer patients.
How similar studies have gone: While specific outcomes from similar studies are not detailed, Fred Hutchinson Cancer Center is known for its impactful cancer research, suggesting a history of successful approaches.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Stamatatos, Leonidas — Fred Hutchinson Cancer Center
- Study coordinator: Stamatatos, Leonidas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.